https://www.selleckchem.com/pr....oducts/Romidepsin-FK
5 kg/m , respectively. The mean BMI showed a drop from 42.0 to 31.7 (P .001) 1 year post revisional surgery for the LRSG group and 42.7 to 34.5 (P .001) for the rLRYGB group, correlating to an excess weight loss (EWL) of 61.7% and 48.1%, respectively. At 5 years post revisional surgery, LRSG patients showed an increase in BMI to 33.8 (EWL = 45.3%), while those who underwent rLRYGB showed a decrease to 34.3 (EWL = 49.2%). Completeness of follow-up at 1, 3, and 5 years for rLRYGB and LRSG were 67%, 35%, and 24% and 45%,